Table 3 Reported adverse events with PZ vaccine and their correlation with the dose number
From: A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
PZ vaccine AEFIs | Dose 1 N = 2711 (%) | Dose 2 N = 1051 (%) | Dose 3 N = 189 (%) | p value |
|---|---|---|---|---|
Systemic AEFIs | ||||
 General body pain | 894 (33.0) | 406 (38.6) | 54 (28.6) | 0.001* |
 Fatigue | 700 (25.8) | 483 (46.0) | 53 (28.0) | < 0.001* |
 Headache | 721 (26.6) | 385 (36.6) | 44 (23.3) | < 0.001* |
 Fever | 562 (20.7) | 352 (33.5) | 59 (31.2) | < 0.001* |
 Chills | 516 (19.0) | 313 (29.8) | 42 (22.2) | < 0.001* |
 Nausea | 287 (10.6) | 178 (16.9) | 32 (16.9) | < 0.001* |
 Dyspnea | 174 (6.4) | 108 (10.3) | 12 (6.3) | < 0.001* |
 Abdominal pain | 135 (5.0) | 104 (9.9) | 7 (3.7) | < 0.001* |
 Diarrhea | 165 (6.1) | 70 (6.7) | 12 (6.3) | 0.807 |
 Cough | 151 (5.6) | 83 (7.9) | 13 (6.9) | 0.028* |
 Dizziness | 175 (6.5) | 63 (6.0) | 15 (7.9) | 0.592 |
 Vomiting | 92 (3.4) | 69 (6.6) | 8 (4.2) | < 0.001* |
Local AEFIs | ||||
 Injection site pain | 898 (33.1) | 490 (46.6) | 64 (33.9) | < 0.001* |
 Injection site swelling | 265 (9.8) | 105 (10.0) | 23 (12.2) | 0.567 |
 Injection site erythema | 188 (6.9) | 51 (4.9) | 7 (3.7) | 0.02* |